GleamWall
中文EN

NATR NATURES SUNSHINE PRODUCTS INC

Pharmaceutical Preparations · Nasdaq · SEC CIK 275053 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.2%
TTM net income YoY-2.9%
TTM EPS YoY1.2%
Revenue 3-yr CAGR3.0%
Net income 3-yr CAGR22.0%

Margins

Gross margin73.1%
Operating margin5.3%
Net margin3.1%
FCF margin2.2%
EBITDA margin8.1%

Returns

ROE8.8%
ROA5.5%
ROIC (approx.)21.5%
Asset turnover1.80x

Leverage & solvency

Liabilities / assets36.0%
Debt / equity0.00x
Current ratio2.56x
Interest coverage176.76x

Cash quality & payout

Operating cash flow / net income1.34x
Accruals ratio-1.9%
Payout ratio—
Capex / revenue1.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$116.60M$116.98M$122.89M$123.81M$128.34M$114.75M$113.25M$118.20M
Cost of revenue$31.64M$30.81M$32.91M$34.03M$34.29M$32.45M$31.65M$33.14M
Gross profit$84.96M$86.17M$89.98M$89.78M$94.05M$82.30M$81.60M$85.06M
SG&A expense$42.31M$44.88M$43.54M$48.42M$45.73M$43.66M$40.58M$43.71M
Operating income$5.28M$5.48M$9.54M$5.32M$8.97M$4.27M$6.17M$4.55M
Interest expense$30,000$53,000$35,000$27,000$26,000$24,000$21,000$5,000
Pretax income$5.37M$5.37M$8.15M$5.49M$9.67M$7.54M$7.11M$1.45M
Income tax$3.48M$1.83M$3.04M$974,000$4.14M$2.02M$2.23M$2.18M
Net income$1.89M$3.54M$5.12M$4.11M$5.33M$5.33M$4.75M-$321,000
EBITDA$8.49M$8.78M$12.77M$8.63M$12.51M$7.77M$9.67M$8.57M
EPS (basic)0.110.200.29—0.300.290.26—
EPS (diluted)0.110.190.29—0.300.280.25—
Weighted avg. shares (diluted)17.87M18.34M17.93M—18.03M18.97M18.85M—
Balance sheet
Cash & equivalents$89.38M$82.50M$87.58M$93.89M$95.55M$81.34M$86.49M$84.70M
Receivables$18.32M$13.86M$12.55M$8.60M$15.11M$13.03M$11.41M$9.48M
Inventory$71.29M$71.73M$67.13M$68.31M$67.33M$69.32M$64.93M$59.44M
Current assets$188.38M$178.40M$178.59M$178.84M$186.08M$171.84M$170.78M$160.58M
PP&E, net$29.70M$30.95M$31.41M$32.91M$33.97M$35.93M$37.70M$39.59M
Total assets$268.23M$259.82M$261.46M$261.15M$264.81M$254.88M$252.70M$240.85M
Current liabilities$73.49M$68.75M$71.37M$78.54M$83.65M$75.85M$70.74M$65.69M
Total liabilities$96.55M$90.51M$94.54M$99.59M$98.10M$91.19M$85.60M$79.86M
Shareholders' equity$171.68M$169.32M$166.92M$161.55M$160.50M$157.68M$161.28M$155.31M
Shares outstanding17.39M17.61M17.56M17.51M17.56M17.64M18.47M18.48M
Cash flow statement
Operating cash flow$10.75M$835,000-$1.85M$9.90M$18.47M$4.34M$2.61M$12.18M
Capital expenditure$1.54M$2.78M$2.48M$2.34M$1.68M$1.35M$1.11M$2.19M
Free cash flow$9.21M-$1.94M-$4.33M$7.56M$16.79M$2.99M$1.50M$9.99M
Investing cash flow-$1.54M-$2.78M-$2.48M-$2.34M-$1.68M-$1.35M-$1.11M-$2.19M
Financing cash flow-$3.56M-$3.46M-$1.58M-$8.53M-$2.40M-$12.12M-$731,000-$576,000
Depreciation & amortization$3.21M$3.30M$3.22M$3.31M$3.54M$3.50M$3.50M$4.02M
Stock-based compensation$1.96M$1.99M$1.64M$1.56M$1.28M$1.64M$1.30M$1.21M
Share buybacks$3.53M$2.06M$500,000$1.93M$2.02M$11.88M$476,000$423,000

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.